← Back to Search

Cognitive Reappraisal for Suicide Prevention (CRISP Trial)

N/A
Recruiting
Led By Dimitris Kiosses, PhD
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
50 years and older
Diagnosis of any DSM-5 depression or anxiety diagnosis based on SCID-5 Clinical Trials Version
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 6, 12, and 24 weeks
Awards & highlights

CRISP Trial Summary

This trial is testing a new intervention to reduce suicide risk for adults aged 50-90 who have been hospitalized for suicidal thoughts or attempts.

Who is the study for?
This trial is for adults aged 50-90 who have recently been hospitalized for suicidal thoughts or attempts. Participants must have a diagnosis of depression or anxiety, be on psychotropics, and receiving community psychotherapy. Excluded are those with psychotic disorders, bipolar I/II in manic states, dementia, severe medical issues, or language/sensory barriers.Check my eligibility
What is being tested?
The study tests a new emotion-regulation intervention aimed at reducing suicide risk against supportive therapy. It targets middle-aged and older adults post-suicide-related hospitalization to see if the novel approach can better prevent future crises.See study design
What are the potential side effects?
While specific side effects aren't listed for this psychological intervention trial, participants may experience emotional discomfort or distress during therapy sessions as they work through difficult feelings and experiences.

CRISP Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 50 years old or older.
Select...
I have been diagnosed with depression or anxiety.

CRISP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 6, 12, and 24 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 6, 12, and 24 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Emotion Regulation, as measured by the Electroencephalogram (EEG), Autobiographical Affective Regulation Task (AART), and a standard picture-based emotion regulation task.
Other outcome measures
Change in Suicide Severity, as measured by the Columbia Suicide Severity Rating Scale (CSSR-S)

CRISP Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: CRISPExperimental Treatment1 Intervention
Cognitive Reappraisal Intervention for Suicide Prevention (CRISP) is a psychosocial intervention aimed to reduce suicide risk in middle-aged and older adults who have been hospitalized for suicidal ideation or suicide attempt. CRISP offers a combination of emotion regulation techniques, including changing the subject's perspective or the way he/she thinks to improve emotion reactions. Additional strategies taught include the provision of environmental adaptation tools (notes, checklists, calendars, etc), phone calls, and a tablet application called WellPATH.
Group II: Supportive Therapy (ST)Active Control1 Intervention
Supportive Therapy focuses on: 1. facilitating expression of affect; 2. conveying to the patient that he or she is understood; 3. offering empathy; and 4. highlighting positive experiences. The ST manual aims to standardize nonspecific therapeutic factors.

Find a Location

Who is running the clinical trial?

Stanford UniversityOTHER
2,378 Previous Clinical Trials
17,333,269 Total Patients Enrolled
Weill Medical College of Cornell UniversityLead Sponsor
1,052 Previous Clinical Trials
1,329,782 Total Patients Enrolled
Florida State UniversityOTHER
197 Previous Clinical Trials
30,558 Total Patients Enrolled
2 Trials studying Suicide Prevention
125 Patients Enrolled for Suicide Prevention

Media Library

Cognitive Reappraisal Intervention for Suicide Prevention Clinical Trial Eligibility Overview. Trial Name: NCT03026127 — N/A
Suicide Prevention Research Study Groups: CRISP, Supportive Therapy (ST)
Suicide Prevention Clinical Trial 2023: Cognitive Reappraisal Intervention for Suicide Prevention Highlights & Side Effects. Trial Name: NCT03026127 — N/A
Cognitive Reappraisal Intervention for Suicide Prevention 2023 Treatment Timeline for Medical Study. Trial Name: NCT03026127 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies available for potential participants of this medical experiment?

"Affirmative. According to clinicaltrials.gov, the research is accepting new participants and was first posted on March 28th 2017 with a recent update on May 17th 2022. The trial needs 90 individuals from one centre to take part in this investigation."

Answered by AI

Does the age of applicants have any bearing on eligibility for this clinical experiment?

"This medical trial requires patients to be between the ages of 50 and 90. In contrast, there are 57 trials for those younger than 18 years old and 117 for seniors exceeding 65 years of age."

Answered by AI

How many participants are receiving treatment through this clinical trial?

"Affirmative. Patient recruitment for this clinical trial is ongoing, as seen on the listing posted to clinicaltrials.gov dated March 28th 2017 and updated May 17th 2022. This experiment needs 90 participants from a single medical center."

Answered by AI

Am I able to enroll in this experiment?

"This medical trial seeks 90 elderly individuals aged between 50 and 90 who are suffering from depression or anxiety. The DSM-5 diagnosis criteria (from the SCID-5 Clinical Trials Version) must be used to determine patient eligibility."

Answered by AI
~4 spots leftby Aug 2024